Prognostic factors of the Pharynx and Supraglottic Carcinoma

The analysis was carried out with a set of 60 patients suffering from carcinoma of the pharynx and supraglottis treated at the Clinic of Otorhinolaryngology and Head and Neck Surgery in Brno within 1991–1999. Most patients (96,7%) underwent neoadjuvant chemotherapy that, because of statistical evaluation, was divided into 5 groups, followed by surgery and postoperative irradiation. Besides routine examinations, flow cytometric analysis of DNA was performed and Ki-67 marker was established by means of immunohistochemistry. The statistical analysis of results in our set has shown the importance of monitoring tumor…